DOJ Cleared Its Own FBI Director in Two Days

Introduction

The FBI investigates financial crimes for a living. Its director, Kash Patel, spent 186 days not disclosing a six-figure stock purchase that federal law required him to report within 45. The stock was MicroStrategy, a company that has billed his own agency more than $4 million over the years. He filed 141 days past the deadline, and two days later a lawyer inside his own department signed off: no conflict.

This story is developing. Details may change.

The trade that wasn't on the form

The STOCK Act is a transparency rule, not an obscure one. Passed in 2012, it requires senior federal officials to publicly report any securities trade over $1,000 within 45 days, so the public can see close to real time when the people running the government are also working the market. Members of Congress live under it. So does the director of the FBI. The 45-day deadline is printed on the disclosure form Patel signed.

Patel bought his MicroStrategy stake on November 21, 2025, which set a reporting deadline of January 5, 2026. He had already filed a periodic transaction report on December 4, using a 30-day extension he'd requested, and the Office of Government Ethics certified it on December 30. That report listed exactly one trade, a sale of ON Semiconductor stock from October. The MicroStrategy purchase, worth up to $250,000, wasn't on it, and it didn't surface anywhere until May 26, 2026, when Patel wrote to DOJ's ethics office asking to amend the report and add the trade he'd "inadvertently omitted."

MicroStrategy isn't a random ticker for a story like this. The company, which rebranded to "Strategy" in August 2025 and now functions largely as a corporate stockpile of bitcoin, has been a federal vendor for years, including to the FBI specifically. Between 2011 and 2019 it held at least six direct FBI contracts for software licenses and maintenance, worth about $4.37 million combined, according to federal spending records. So the head of the FBI bought a six-figure position in one of the FBI's own software vendors, then didn't report it.

Two things matter here beyond the missed deadline. The stock is tied to a company that does business with his agency, and the only conflict review that exists came from inside his own department, not from anyone independent of it.

"No current conflict exists"

The amendment is a public document, and the part that matters is in the fine print. Patel's May 26 letter asks the ethics office to add the MicroStrategy purchase, and it carries an endnote in his own words: "No current conflict exists. Recusal or divestiture will occur should one arise." That's the filer assessing his own trade, written into a correction filed months after the fact.

Two days later, on May 28, Deputy Assistant Attorney General William N. Taylor II sent the amendment on to the Office of Government Ethics with a line of his own. Taylor, one of DOJ's alternate designated agency ethics officials, wrote that he had "reviewed the updated information" and "continue[s] to believe that Director Patel is in compliance with applicable laws and regulations governing conflicts of interest" — the entire review. Taylor also attributed the omission to a "miscommunication," a word that appears nowhere in Patel's letter, which says only that the trade was "inadvertently omitted."

The detail I keep coming back to is that the original form did disclose a trade, just not this one. It listed Patel's October sale of ON Semiconductor. The MicroStrategy purchase, larger and made a month later, was the omission nobody could see until May.

That vendor relationship is documented, though it comes with a caveat worth stating plainly. Federal spending data shows MicroStrategy's biggest FBI award was a roughly $2 million software-license and maintenance contract running from 2011 to 2012, plus five smaller maintenance awards through 2019. There's no direct FBI contract in the database after that, so this is a documented, recurring relationship rather than proof of an open FBI deal today. The company still claims the connection: its federal-government sales page, the same one NOTUS links in its report, lists "GSA, NASA, and the FBI" among agencies that use its software, sold through authorized federal resellers and backed by FedRAMP Moderate authorization.

The watchdog reaction was not hedged. Dylan Hedtler-Gaudette of the Project On Government Oversight told NOTUS the disclosure was "absolutely" late under the letter of the STOCK Act. "That's violating the law — no other way to put it," he said.

Who Benefits

Patel got two things from the delay. One is ordinary market exposure to a volatile stock while running the agency with jurisdiction over securities and crypto fraud. The other is quieter and more valuable: for six months, nobody knew he held it. A trade reported on time invites questions while it's fresh. Reporting it late kept it invisible through the entire window when those questions would have landed.

MicroStrategy gets something softer than a contract and arguably more useful: a sitting FBI Director as a personal shareholder, right as the company leans into federal sales. Its bitcoin-heavy balance sheet has been battered, and its pitch to government buyers depends on projecting the stability of a trusted institution. The head of federal law enforcement quietly holding his stake isn't something the company would put in a press release. It reads as a vote of confidence to the crypto-friendly investors it needs, if they ever notice.

Patel isn't the only person in the administration with money on this stock. Strategy's executive chairman, Michael Saylor, attended Trump's first White House crypto summit in March 2025, and Eric Trump has described a two-decade friendship with him. President Trump's own 2026 financial disclosure, reviewed by Fortune, shows active trading of MicroStrategy shares across several accounts, in the $15,000 to $50,000 range per trade. The company chasing federal business has personal financial threads running through both the FBI Director and the President at once.

Graded by the home team

Take out the crypto and the politics and you're left with a plain structural problem. The only entity that formally reviewed whether the FBI Director had a conflict of interest was the ethics office of the department the FBI sits inside. No outside referee touches this process. Designated agency ethics officials and their alternates work within the department, advising and certifying the same officials they work alongside. The Office of Government Ethics receives these forms and certifies that they're complete; it doesn't adjudicate whether a given holding is a conflict. That judgment came entirely from within DOJ.

When the person under review is one of the most powerful figures in the department, "we looked at it and found nothing" and "no one independent looked at it" describe the same two days in May.

This is also where the enforcement machinery shows how little it enforces. A first STOCK Act violation carries a $200 late fee that ethics officials waive as a matter of routine, and Patel hasn't been charged even that. He's far from alone. NOTUS counted more than 30 members of Congress who filed tardy STOCK Act disclosures in the past year, and a Business Insider investigation found 78 members of the 117th Congress had blown the law's deadlines, almost all without penalty. When the fine is nominal and usually waived, on-time disclosure is the only real accountability the law has. Patel missed it by 141 days.

His defense has real substance. Nobody has alleged he traded on inside information or that his MicroStrategy stake bent a single FBI or DOJ decision, and the position has been a loser, down roughly 48% since November by BeInCrypto's count carried by Yahoo News, with some analysts bullish only on a turnaround the company announced afterward. His filing calls the omission inadvertent, and you can take that at face value. It doesn't change who signed off on it.

The Bottom Line

The paper trail isn't really in dispute. A six-figure trade in an agency vendor went unreported for 186 days, the correction landed 141 days past a federal deadline, and the only conflict review that exists came from a lawyer in the same department. All of it is documented, including by Patel's own filing.

What's missing is anyone with the independence to say whether it's actually fine. Congress could take that up, and as of this writing no committee has sent a letter about the MicroStrategy trade specifically. Until one does, the official answer to whether the head of the FBI had a conflict of interest is the one his own department reached in two days: no.